Funding for this research was provided by:
Natural Science Foundation of Shanghai (19ZR1407400)
Clinical Research Plan of SHDC (SHDC2020CR3071B)
Received: 22 March 2022
Accepted: 23 May 2022
First Online: 28 July 2022
: This study was approved by the institute’s ethical committee (Approval letter No. 2021 − 457).
: Participants enrolled into the study agreed the use of data for research.
: The authors declare that they have no competing interests.